The researchers integrate near-infrared fluorescence imaging with indocyanine green-loaded tumor-derived nanoparticles to enhance the precision of tumor and lymph node removal in dogs, aiming to reduce recurrence and advance surgical oncology.

The FIP Projekt Bern is a collaboration between the Small Animal Clinic and the Institute of Virology and Immunology that focuses on characterizing feline coronavirus strains while providing antiviral treatment to cats with FIP in Switzerland.

The researchers aim to improve the understanding of bovine spastic syndrome in Swiss dairy cattle by defining the phenotype, estimating the prevalence and identifying the underlying possible genetic causes.

This study measures how quickly two inflammatory proteins, CRP and REG3E, change in blood of dogs in health, after sterile surgery, and with sepsis. Understanding protein kinetics will help to better diagnose inflammation and infection.

Researchers at the Vetsuisse Faculty aim to improve diagnosis of pituitary pars intermedia dysfunction in ageing horses by validating β-endorphin as a biomarker and clarifying its relationship with clinical signs and age to support more ...

The researcher aims to identify genetic markers associated with major hoof lesions in Swiss dairy cattle and provide tools for genetic selection that improve animal health, welfare and productivity while reducing lameness-related losses on farms.

TMHS is a painful neuropathic condition affecting horses. The researchers aim to develop a controlled rhizotomy for the treatment of horses with TMHS refractory to medical management, using advanced imaging and surgical navigation techniques.

REG3E, a novel inflammatory marker for dogs, was recently discovered at the Vetsuisse Faculty Bern. This study explores which tissues produce this protein in health and infection, to help interpret high values of this protein in blood.

The Vetsuisse Faculty aims to advance the understanding of equine asthma by developing a novel diagnostic test based on alpaca-derived nanobodies targeting CXCL13, a promising biomarker for this frequent respiratory disease in horses.

The researchers use proteomic profiling of extracellular vesicles from dogs with mast cell tumors to identify biomarkers of minimal residual disease and recurrence, aiming to advance liquid biopsy approaches in veterinary oncology.